Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M deMattos

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drugs|January 29, 2000
A practical guide to the management of hypertension in renal transplant recipientsA J Olyaei, A M deMattos, W M Bennett
Current Opinion in Nephrology and Hypertension|September 16, 2000
Renal toxicity of protease inhibitorsA J Olyaei, A M deMattos, W M Bennett
Drug Safety|June 1, 1997
Switching between cyclosporin formulations. What are the risks?A J Olyaei, A M deMattos, W M Bennett
Progress in Transplantation (Aliso Viejo, Calif.)|May 19, 2001
Use of basiliximab and daclizumab in kidney transplantationA J Olyaei, K Thi, A M deMattos, et al.
Pharmacotherapy|December 17, 1998
Interaction between tacrolimus and nefazodone in a stable renal transplant recipientA J Olyaei, A M deMattos, D J Norman, et al.
The Journal of Urology|May 20, 1999
Kidney transplantation in children: a single center experienceD B Lashley, J M Barry, A M Demattos, et al.
Transplantation|September 12, 1998
Efficacy and safety of low molecular weight heparin in renal transplantationA M Alkhunaizi, A J Olyaei, J M Barry, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drugs|January 29, 2000
A practical guide to the management of hypertension in renal transplant recipientsA J Olyaei, A M deMattos, W M Bennett
Current Opinion in Nephrology and Hypertension|September 16, 2000
Renal toxicity of protease inhibitorsA J Olyaei, A M deMattos, W M Bennett
Drug Safety|June 1, 1997
Switching between cyclosporin formulations. What are the risks?A J Olyaei, A M deMattos, W M Bennett
Progress in Transplantation (Aliso Viejo, Calif.)|May 19, 2001
Use of basiliximab and daclizumab in kidney transplantationA J Olyaei, K Thi, A M deMattos, et al.
Pharmacotherapy|December 17, 1998
Interaction between tacrolimus and nefazodone in a stable renal transplant recipientA J Olyaei, A M deMattos, D J Norman, et al.
The Journal of Urology|May 20, 1999
Kidney transplantation in children: a single center experienceD B Lashley, J M Barry, A M Demattos, et al.
Transplantation|September 12, 1998
Efficacy and safety of low molecular weight heparin in renal transplantationA M Alkhunaizi, A J Olyaei, J M Barry, et al.
Pageof 1